Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found four genes that could help diagnose severe alopecia areata early.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

miR-29 is a key factor that accelerates aging.

The document explains the genetic causes and characteristics of inherited hair disorders.

Many research paper titles in dermatology journals lack scientific precision.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Immune cells and cytokines significantly affect pathological scar development.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Hair loss from multiple sclerosis treatments is usually temporary.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Melatonin can improve treatment and extend remission for certain skin conditions.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.